{"id":"https://openalex.org/W1690635788","doi":"https://doi.org/10.18632/oncotarget.4254","title":"A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives","display_name":"A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives","publication_year":2015,"publication_date":"2015-06-12","ids":{"openalex":"https://openalex.org/W1690635788","doi":"https://doi.org/10.18632/oncotarget.4254","mag":"1690635788","pmid":"https://pubmed.ncbi.nlm.nih.gov/26308162","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4694955"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.4254","doi":"https://doi.org/10.18632/oncotarget.4254","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.4254","pdf_url":"https://www.oncotarget.com/article/4254/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.oncotarget.com/article/4254/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008894786","display_name":"Alessandro Russo","orcid":"https://orcid.org/0000-0002-3365-1972","observed_orcids":["https://orcid.org/0000-0002-3365-1972"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandro Russo","raw_affiliation_strings":["Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103027164","display_name":"Tindara Franchina","orcid":"https://orcid.org/0000-0001-5920-4997","observed_orcids":["https://orcid.org/0000-0001-5920-4997"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Tindara Franchina","raw_affiliation_strings":["Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107425833","display_name":"Giuseppina Rosaria Rita Ricciardi","orcid":"https://orcid.org/0000-0002-7282-3597","observed_orcids":["https://orcid.org/0000-0002-7282-3597"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppina Rosaria Rita Ricciardi","raw_affiliation_strings":["Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010095820","display_name":"Antonio Picone","orcid":"https://orcid.org/0009-0006-0924-2163","observed_orcids":["https://orcid.org/0009-0006-0924-2163"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonio Picone","raw_affiliation_strings":["Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001106275","display_name":"Giuseppa Ferraro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppa Ferraro","raw_affiliation_strings":["Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081361487","display_name":"Mariangela Zangh\u00ec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mariangela Zangh\u00ec","raw_affiliation_strings":["Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077167101","display_name":"Giuseppe Toscano","orcid":"https://orcid.org/0000-0003-1423-7060","observed_orcids":["https://orcid.org/0000-0003-1423-7060"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Toscano","raw_affiliation_strings":["Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024798356","display_name":"Antonio Giordano","orcid":"https://orcid.org/0000-0002-5959-016X","observed_orcids":["https://orcid.org/0000-0002-5959-016X"]},"institutions":[{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonio Giordano","raw_affiliation_strings":["Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, Pennsylvania, USA","institution_ids":["https://openalex.org/I84392919"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054443196","display_name":"Vincenzo Adamo","orcid":"https://orcid.org/0000-0003-2074-2418","observed_orcids":["https://orcid.org/0000-0003-2074-2418"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vincenzo Adamo","raw_affiliation_strings":["Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit AOOR Papardo-Piemonte & Department of Human Pathology, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.9274,"has_fulltext":true,"cited_by_count":177,"citation_normalized_percentile":{"value":0.9804172,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"6","issue":"29","first_page":"26814","last_page":"26825"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer","display_name":"EGFR-mutant non-small cell lung cancer","score":0.9470000267028809},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9679999947547913},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/irreversible-egfr-inhibitors","display_name":"irreversible EGFR inhibitors","score":0.8050000071525574},{"id":"https://openalex.org/keywords/mutant-selective-inhibitors","display_name":"mutant-selective inhibitors","score":0.8460000157356262},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9079999923706055},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.9819999933242798},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6949999928474426},{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.9190369248390198},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.9019733667373657},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7846550345420837},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7117982506752014},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6380302309989929},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5936044454574585},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5857818722724915},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.5524680018424988},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.5194206237792969},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4412746727466583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42932868003845215},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.42910295724868774},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39395251870155334},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3231585621833801},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.29412391781806946},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11352905631065369},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10893911123275757},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.10247904062271118}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008495","descriptor_name":"Medical Oncology","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.18632/oncotarget.4254","doi":"https://doi.org/10.18632/oncotarget.4254","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.4254","pdf_url":"https://www.oncotarget.com/article/4254/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmid:26308162","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26308162","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4694955","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4694955/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"},{"id":"pmh:oai:null:20.500.12613/4201","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/20.500.12613/4201","pdf_url":null,"source":{"id":"https://openalex.org/S4306402624","display_name":"TUScholarShare (Temple University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84392919","host_organization_name":"Temple University","host_organization_lineage":["https://openalex.org/I84392919"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:usiena-air.unisi.it:11365/997532","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11365/997532","pdf_url":null,"source":{"id":"https://openalex.org/S4377196319","display_name":"Use Siena air (University of Siena)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I102064193","host_organization_name":"University of Siena","host_organization_lineage":["https://openalex.org/I102064193"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.4254","doi":"https://doi.org/10.18632/oncotarget.4254","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.4254","pdf_url":"https://www.oncotarget.com/article/4254/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1690635788.pdf","grobid_xml":"https://content.openalex.org/works/W1690635788.grobid-xml"},"referenced_works_count":108,"referenced_works":["https://openalex.org/W8665794","https://openalex.org/W1534608409","https://openalex.org/W1712727770","https://openalex.org/W1884843684","https://openalex.org/W1965850768","https://openalex.org/W1974935634","https://openalex.org/W1978401308","https://openalex.org/W1980497534","https://openalex.org/W1983159571","https://openalex.org/W1986034271","https://openalex.org/W1990013637","https://openalex.org/W1994499102","https://openalex.org/W2002428607","https://openalex.org/W2004824099","https://openalex.org/W2005728761","https://openalex.org/W2014993624","https://openalex.org/W2019582655","https://openalex.org/W2020600748","https://openalex.org/W2022572106","https://openalex.org/W2025208846","https://openalex.org/W2027242209","https://openalex.org/W2028315898","https://openalex.org/W2029745956","https://openalex.org/W2030227571","https://openalex.org/W2037873277","https://openalex.org/W2038268416","https://openalex.org/W2040561412","https://openalex.org/W2043696829","https://openalex.org/W2057942347","https://openalex.org/W2063391304","https://openalex.org/W2065477010","https://openalex.org/W2069312070","https://openalex.org/W2076178766","https://openalex.org/W2076883919","https://openalex.org/W2082664617","https://openalex.org/W2088540000","https://openalex.org/W2093922887","https://openalex.org/W2095618958","https://openalex.org/W2096198395","https://openalex.org/W2097152766","https://openalex.org/W2101329867","https://openalex.org/W2102625113","https://openalex.org/W2104748005","https://openalex.org/W2105026490","https://openalex.org/W2107304950","https://openalex.org/W2108371618","https://openalex.org/W2108586722","https://openalex.org/W2109080255","https://openalex.org/W2110835998","https://openalex.org/W2110841878","https://openalex.org/W2111109297","https://openalex.org/W2111662961","https://openalex.org/W2111710483","https://openalex.org/W2113508099","https://openalex.org/W2113521542","https://openalex.org/W2113762115","https://openalex.org/W2114464493","https://openalex.org/W2120111652","https://openalex.org/W2120718661","https://openalex.org/W2121641332","https://openalex.org/W2126177831","https://openalex.org/W2126181231","https://openalex.org/W2127101185","https://openalex.org/W2128688922","https://openalex.org/W2129360604","https://openalex.org/W2129656399","https://openalex.org/W2130256619","https://openalex.org/W2132157071","https://openalex.org/W2132870547","https://openalex.org/W2133963438","https://openalex.org/W2135192471","https://openalex.org/W2137005514","https://openalex.org/W2138297714","https://openalex.org/W2143913849","https://openalex.org/W2146418087","https://openalex.org/W2146633923","https://openalex.org/W2149733252","https://openalex.org/W2150575159","https://openalex.org/W2151039595","https://openalex.org/W2152755651","https://openalex.org/W2152905269","https://openalex.org/W2153080167","https://openalex.org/W2153477391","https://openalex.org/W2153800888","https://openalex.org/W2153865661","https://openalex.org/W2154130790","https://openalex.org/W2154149901","https://openalex.org/W2154662831","https://openalex.org/W2154996469","https://openalex.org/W2155946891","https://openalex.org/W2160982674","https://openalex.org/W2161472240","https://openalex.org/W2161821474","https://openalex.org/W2162724777","https://openalex.org/W2166084034","https://openalex.org/W2168554121","https://openalex.org/W2168841302","https://openalex.org/W2168856723","https://openalex.org/W2169816570","https://openalex.org/W2171139285","https://openalex.org/W2180481128","https://openalex.org/W2259557965","https://openalex.org/W2260089498","https://openalex.org/W2322882417","https://openalex.org/W2462237620","https://openalex.org/W2465149354","https://openalex.org/W2526148797","https://openalex.org/W2596364503"],"related_works":["https://openalex.org/W203184252","https://openalex.org/W2032471719","https://openalex.org/W1918002298","https://openalex.org/W4233613384","https://openalex.org/W211008619","https://openalex.org/W2588285365","https://openalex.org/W2584153090","https://openalex.org/W177903961","https://openalex.org/W2946214599","https://openalex.org/W2313863158"],"abstract_inverted_index":{"The":[0,151],"discovery":[1],"of":[2,19,34,43,51,118,130,153,162,177],"Epidermal":[3],"Growth":[4],"Factor":[5],"Receptor":[6],"(EGFR)":[7],"mutations":[8,45],"in":[9,22,30,46,54,83,106,143,169,173,206],"Non":[10],"Small":[11],"Cell":[12],"Lung":[13],"Cancer":[14],"(NSCLC)":[15],"launched":[16],"the":[17,31,41,47,52,59,89,137,163,170,181,193,201,207],"era":[18],"personalized":[20],"medicine":[21],"advanced":[23,84],"NSCLC,":[24],"leading":[25],"to":[26,58,139,157,192,212],"a":[27,79,159],"dramatic":[28],"shift":[29],"therapeutic":[32,125],"landscape":[33],"this":[35,154,174],"disease.":[36],"After":[37],"ten":[38],"years":[39],"from":[40,180],"individuation":[42],"activating":[44],"tyrosine":[48,61],"kinase":[49,62],"domain":[50],"EGFR":[53,60,76,93,171,187],"NSCLC":[55,86,178],"patients":[56,122],"responding":[57],"inhibitor":[63],"(TKI)":[64],"Gefitinib,":[65,191],"several":[66],"progresses":[67,165],"have":[68,95,101,114],"been":[69,96,102,115],"done":[70],"and":[71,98,190,196,199],"first":[72,185],"line":[73],"treatment":[74,117],"with":[75,184],"TKIs":[77,94],"is":[78,156],"firmly":[80],"established":[81],"option":[82],"EGFR-mutated":[85],"patients.":[87,109],"During":[88],"last":[90],"decade,":[91],"different":[92],"developed":[97],"three":[99],"inhibitors":[100,198],"approved":[103],"so":[104,167],"far":[105,168],"these":[107,119,141],"selected":[108,121],"However,":[110],"despite":[111],"great":[112],"breakthroughs":[113],"made,":[116],"molecularly":[120],"poses":[123],"novel":[124,194],"challenges,":[126],"such":[127,147],"as":[128,148],"emerging":[129,202],"acquired":[131],"resistance,":[132],"brain":[133],"metastases":[134],"development":[135],"or":[136],"need":[138],"translate":[140],"treatments":[142],"earlier":[144],"clinical":[145],"settings,":[146],"adjuvant":[149],"therapy.":[150],"aim":[152],"paper":[155],"provide":[158],"comprehensive":[160],"review":[161],"major":[164],"reported":[166],"inhibition":[172],"molecularly-selected":[175],"subgroup":[176],"patients,":[179],"early":[182],"successes":[183],"generation":[186],"TKIs,":[188],"Erlotinib":[189],"irreversible":[195],"mutant-selective":[197],"ultimately":[200],"challenges":[203],"that":[204],"we,":[205],"next":[208],"future,":[209],"are":[210],"called":[211],"deal":[213],"with.":[214]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":20},{"year":2018,"cited_by_count":24},{"year":2017,"cited_by_count":29},{"year":2016,"cited_by_count":33},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}
